Skip to main content
See every side of every news story
Published loading...Updated

Cardiac Repair Promoted by Cyclin A2, Potential Heart Transplant Alternative

Reactivating Cyclin A2 gene prompts adult heart cells from donors aged 41 and 55 to divide and function normally, potentially enabling heart repair without transplants, study shows.

  • On November 3, 2025, Mount Sinai researchers led by Hina Chaudhry reported that reactivating the Cyclin A2 gene can produce new, functioning adult human heart cells, published in npj Regenerative Medicine.
  • Because adult human heart muscle cells stop dividing after birth, the heart cannot replace cells lost to heart attack or heart failure, researchers say.
  • Using a replication‑deficient human‑compatible viral vector, researchers delivered CCNA2 to donor hearts aged 21, 41 and 55 and used time‑lapse imaging to confirm division in 41‑ and 55‑year‑old cells with functional daughter cells.
  • The researchers plan to seek Food and Drug Administration approval to test CCNA2 therapy in patients with heart disease, aiming to let the heart heal itself and reduce transplant needs.
  • Researchers caution that delivering the gene safely inside a living heart and ensuring controlled regeneration will be challenging, while Dr. Hina Chaudhry called it `This is the culmination of nearly two decades of work.
Insights by Ground AI

13 Articles

Lean Left

It "turns back time" for cells.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 60% of the sources are Center
60% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Monday, November 3, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal